Post cardiopulmonary bypass renal failure – do we need goal directed perfusion?

Authors

  • Paulo Neves Serviço de Cirurgia Cardiotorácica; Centro Hospitalar de Vila Nova de Gaia/Espinho, EPE, Vila Nova de Gaia, Portugal

DOI:

https://doi.org/10.48729/pjctvs.120

Abstract

.

Downloads

Download data is not yet available.

References

Lagny M-G, Jouret F, Koch J-N, et al. Incidence and outcomes of acute kidney injury after cardiac surgery using either criteria of the RIFLE classification. BMC Nephrol 2015;16:76

Hobson CE, Yavas S, Segal MS, et al. Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery. Circulation 2009;119(18):2444-2453

O'Neal JB, Shaw AD, Billings FT IV. Acute kidney injury following cardiac surgery: current understanding and future directions. Crit Care 2016;20(01):187

Zou H, Hong Q, Xu G. Early versus late initiation of renal replacement therapy impacts mortality in patients with acute kidney injury post cardiac surgery: a meta-analysis. Crit Care 2017;21 (01):150

Karvellas CJ, Farhat MR, Sajjad I, et al. A comparison of early versus late initiation of renal replacement therapy in critically ill patients with acute kidney injury: a systematic review and meta-analysis. Crit Care 2011;15(01):R72

Ranucci M, Pavesi M, Mazza E, Bertucci C, Frigiola A, Menicanti L, et al. Risk factors for renal dysfunction after coronary surgery: the role of cardiopulmonary bypass technique. Perfusion. 1994;9:319-26.

Karkouti K, Beattie WS, Wijeysundera DN, Rao V, Chan C, Dattilo KM, et al. Hemodilution during cardiopulmonary bypass is an independent risk factor for acute renal failure in adult cardiac surgery. J Thorac Cardiovasc Surg. 2005; 129:391-400.

Ranucci M, Romitti F, Isgro G, Cotza M, Brozzi S, Boncilli A, et al. Oxygen delivery during cardiopulmonary bypass and acute renal failure after coronary operations. Ann Thorac Surg. 2005;80:2213-20.

Ranucci M, Johnson I, Willcox T, Baker RA, et al. Goal-directed perfusion to reduce acute kidney injury: A randomized trial. J Thorac Cardiovasc Surg. 2018 Nov;156(5):1918-1927.e2.

Haifeng Qin, Fang Wang, Hui Liu, Zhen Zeng, Shasha Wang, Xin Pan, Hongjun Gao. New advances in immunotherapy for non-small cell lung cancer. Am J Transl Res 2018; 10(8):2234-2245. http://www.ajtr.org/files/ajtr0075629.pdf

G.Videtic, J Donington et all. Stereotactic body radiation therapy for early-stage non-small cell lung cancer: Executive Summary of an ASTRO Evidence-Based Guideline. Practical Radiation Oncology (2017) 7,295-301. http://dx.doi.org/10.1016/j.prro.2017.04.014

P. E. Postmus, K. M. Kerr et all. Early-Stage and Locally Advanced (non-metastatic) Non-Small-Cell Lung Cancer: ESMO Clinical Practice Guidelines. Annals of Oncology 28 (Supplement 4): iv1–iv21, 2017. doi:10.1093/annonc/mdx222

Chen-Yang Huang, Bo-Huan Chen, Wen-Chi Chou, Cheng-Ta Yang, John Wen-Cheng Chang. Factors associated with the prognosis and long-term survival of patients with metastatic lung adenocarcinoma: a retrospective analysis. J Thorac Dis 2018;10(4):2070-2078. doi: 10.21037/jtd.2018.03.143

Downloads

Published

26-05-2021

How to Cite

1.
Neves P. Post cardiopulmonary bypass renal failure – do we need goal directed perfusion?. Rev Port Cir Cardiotorac Vasc [Internet]. 2021 May 26 [cited 2023 Feb. 3];26(2):91-2. Available from: https://pjctvs.com/index.php/journal/article/view/120

Issue

Section

Editorial Comment

Most read articles by the same author(s)